Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based study.

about

Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.Sex-related differences in clinicopathological features and survival of patients with primary urethral carcinoma: a population-based study.

P2860

Q39385461-9C8EDE8C-954E-4A9F-A899-8ACBFA2F8A61 Q40108481-AA4F7128-B5D1-4F56-A991-76E3E33C0A4D

P2860

Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based study.

Item

http://www.wikidata.org/entity/Q41432991

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Does postoperative radiation t ...... carcinoma? A SEER-based study.

@en

type

Item

label

Does postoperative radiation t ...... carcinoma? A SEER-based study.

@en

prefLabel

Does postoperative radiation t ...... carcinoma? A SEER-based study.

@en

P1476

Does postoperative radiation t ...... carcinoma? A SEER-based study

@en

P2093

Ilgar Akbarov

http://www.w3.org/2001/XMLSchema#string

Sebastian Wille

http://www.w3.org/2001/XMLSchema#string

Udo Engelmann

http://www.w3.org/2001/XMLSchema#string

P2860

Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies.

Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?

EAU guidelines on renal cell carcinoma: 2014 update.

Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation.

Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma

A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802

Contemporary imaging of patients with a renal mass: does size on computed tomography equal pathological size?

Difference between clinical and pathologic renal tumor size, correlation with survival, and implications for patient counseling regarding nephron-sparing surgery.

Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition.

Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.

P304

1653-1663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11255-015-1093-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Okyaz Eminaga

P577

2015-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26329746

http://www.w3.org/2001/XMLSchema#string

Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based study.

about

P2860

P2860

Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698